Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 789-795

  Elizalde, J Ignasi ^b   Moitinho, Eduardo ^b   García Pagán, Joan Carles ^b   Cirera, Isabel ^b   Escorsell, Angels ^b   Bandi, Juan Carlos ^b   Jiménez, Wladimiro ^b   Bosch, Jaume ^b   Piqué, Josep M ^a   Rodés, Joan ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Blood viscosity; Portal hypertension; Portal pressure; Systemic vascular resistance; Vascular hindrance

Indexed keywords

PROTEIN;

ADULT; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; ESOPHAGUS VARICES BLEEDING; FEMALE; HEART OUTPUT; HEMODYNAMIC MONITORING; HEMOGLOBIN DETERMINATION; HUMAN; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRESSURE GRADIENT; PRIORITY JOURNAL; VENOUS PRESSURE;

EID: 0032212591     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80260-2     Document Type: Article

References (30)

1. Vorobioff J, Bredfeldt J, Groszmann RJ. Hyperdynamic circulation in a portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 244:1983;G52-G57.
2. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver diseases. Bosch J, Groszmann RJ. 1st ed Portal Hypertension: Pathophysiology and Treatment. 1994;17-26 Blackwell Scientific Publications, Oxford.
3. Pizcueta P, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol. 105:1992;184-190.
4. Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJR, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology. 103:1992;1909-1915.
5. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 16:1992;1043-1048.
6. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 103:1992;235-239.
7. Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 35:1996;6976-6983.
8. Anand IS, Chandrashekhar Y, Wander GS, Chawla LS. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol. 25:1995;1402-1407.
9. Petz LD. Hematologic aspects of liver disease. Current Opinion Gastroenterol. 5:1989;372-377.
10. Casadevall M, Piqué JM, Cirera I, Goldin E, Elizalde I, Panés J, et al. Increased blood hemoglobin attenuates splanchnic vasodilation in portal hypertensive rats by nitric oxide inactivation. Gastroenterology. 110:1996;1156-1165.
11. Cirera I, Elizalde JI, Piqué JM, Feu F, Casadevall M, Goldin E, et al. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci. 42:1997;1697-1702.
12. Denié C, Poynard T, Gadano A, Vachiery F, Soupison T, Elman A, et al. Influence of anemia on hemodynamic changes in patients with cirrhosis. Gastroenterol Clin Biol. 21:1997;29-33.
13. Bosch J, Mastai R, Kravetz D, Navasa M, Rodés J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 6:1986;309-317.
14. Fan FC, Chen RYZ, Schuessler GB, Chien S. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol. 238:1980;H545-H552.
15. Asbert M, Jiménez W, Gaya J, Ginès P, Arroyo V, Rivera F, et al. Assessment of the renin-angiotensin system in cirrhotic patients: comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol. 6:1992;179-183.
16. Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver. Its relation to portal hypertension, ascites, and renal failure. J Clin Invest. 46:1967;1297-1308.
17. Graettinger JS, Parson RL, Campbell JA. A correlation of clinical and hemodynamic studies in patients with mild and severe anemia with and without congestive failure. Ann Intern Med. 58:1963;617-626.
18. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J. 83:1992;415-424.
19. Panés J, Casadevall M, Piqué JM, Bosch J, Whittle BJR, Terés J. Effects of acute normovolemic anemia on gastric mucosal blood flow. Role of nitric oxide. Gastroenterology. 103:1992;407-413.
20. Castro A, Jiménez W, Clària J, Ros J, Martínez JM, Bosch J, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitrix oxide. Hepatology. 18:1993;367-372.
21. Guarner C, Soriano G, Tomás A, Bulbena O, Novella MT, Balanzó J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxins. Hepatology. 18:1993;1139-1143.
22. Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol. 26:1997;75-80.
23. Casadevall M, Piqué JM, Cirera I, Terés J. Acute normovolemic anemia increases gastric blood flow and decreases ethanol-induced gastric damage in portal-hypertensive rats [Abstract]. Gastroenterology. 106:1993;A60.
24. Cirera I, Panés J, Bordas JM, Llach J, Bosch J, Piqué JM, et al. Anemia increases gastric blood flow in noncirrhotic and cirrhotic patients. Gastrointest Endosc. 42:1995;403-407.
25. Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 109:1995;1917-1925.
26. Dalinghaus M, Knoester H, Gratama JW, Van der Meer J, Zijlstra WG, Kuipers JR. Effect of increased whole blood viscosity on regional blood flows in chronically hypoxemic lambs. Am J Physiol. 267:1994;H471-H476.
27. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276:1997;2034-2037.
28. Miller MV, Vanhoutte PM. Enhanced release of endothelin derived factor(s) by chronic increases in blood flow. Am J Physiol. 255:1988;H446-H451.
29. Boyer JL, Chatterjee CC, Iber FL, Basu AK. Effect of plasma-volume expansion on portal hypertension. N Engl J Med. 275:1966;750-755.
30. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, Calmus Y. NO mediated vasodilation in the rat liver. Role of hepatocytes and liver endothelial cells. J Hepatol. 26:1997;1348-1355.